Vikrant Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1984.
1984 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Vikrant Pharmaceuticals Limited

Vikrant Pharmaceuticals Limited, a active public limited company, was established on 16 February 1984 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U99999MH1984PLC032190. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹2.24 Cr.

Formerly known as Vikrant Pharmaceuticals Private Limited. It upholds a compliant status. Its leadership includes Kamala Ladhani Vastupal (Whole-Time Director), Vastupal Ladhani Pratapchand (Managing Director), Shruti Neeraj Ladhani (Director). Past directors included Rakesh Shantilal Shah, Vipin Rupchand Madhani, Vipin Roopchand Madhani. It holds ₹5.01 Cr open charges and ₹2.67 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Govind Nivas, 1St Floor,62/64,Dhanji Street, Mumbai, Maharashtra, 400003.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U99999MH1984PLC032190

  • Registration Number

    032190

  • Incorporation Date

    16 February 1984

  • Authorized Capital

    ₹6.00 Cr

  • Paid-Up Capital

    ₹2.24 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.00 Cr
  • Paid Up Capital ₹ 2.24 Cr
  • Company Age 41 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 5.01 Cr
  • Satisfied Charges ₹ 2.67 M
  • Revenue Growth **** %
  • Profit Growth **** -223.38%
  • Ebitda **** -241.91%
  • Net Worth -0.90%
  • Total Assets -0.92%
Company report

Vikrant Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Vikrant Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Vikrant Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Kamala Ladhani Vastupal Whole-Time Director 15 Mar 1984 Current
Vastupal Ladhani Pratapchand Managing Director 17 Feb 1984 Current
Shruti Neeraj Ladhani Director 27 Dec 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 03 Dec 2009 Past
Pramod Abcsdd Director 16 Apr 2012 Past
Pramod Abcsdd Director 16 Apr 2012 Past
Pramod Abcsdd Additional Director 30 Sep 2017 Past
Pramod Abcsdd Director 13 Apr 2012 Past
Pramod Abcsdd Director 27 Dec 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vikrant Pharmaceuticals.

Vikrant Pharmaceuticals Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 223.38% decrease in profit. The company's net worth dipped by a decrease of 0.9%.

Vikrant Pharmaceuticals revenue growth over time
Vikrant Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -0.92%
*******
*******
*******
*******
Profit or Loss
*******
 -223.38%
*******
*******
*******
*******
Net Worth
*******
 -0.90%
*******
*******
*******
*******
EBITDA
*******
 -241.91%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vikrant Pharmaceuticals?

In 2020, Vikrant Pharmaceuticals had a promoter holding of 16.92% and a public holding of 83.09%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹50,055,000.00

Satisfied Charges

₹2,667,400.00

Charges Breakdown by Lending Institutions
  • Bank Of India : 5.00 Cr
  • Citibank Na : 0.01 Cr
Latest Charge Details
Date Lender Amount Status
29 Nov 2014 Bank Of India ₹5.00 Cr Open
20 Feb 1988 Citibank Na ₹0.06 M Open
05 Jun 2010 Syndicate Bank ₹0.50 M Satisfied
15 Sep 1987 New Bank Of India ₹0.20 M Satisfied
21 Aug 1985 New Bank Of India ₹0.40 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Vikrant Pharmaceuticals?

Unlock and access historical data on people associated with Vikrant Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vikrant Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vikrant Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vikrant Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Vikrant Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Vikrant Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Shruti Neeraj Ladhani was appointed as a Director was appointed as a Director on 27 Dec 2016 & has been associated with this company since 9 years 1 month . was documented.

  • Charges

    The activity A charge with Bank Of India amounted to Rs. 5.00 Cr with Charge ID 10542702 was registered on 29 Nov 2014. was completed.

  • Charges

    A charge registered on 05 Jun 2010 via Charge ID 10229637 with Syndicate Bank was fully satisfied on 18 Apr 2012. was recorded as a recent event.

  • Charges

    Progress on A charge with Syndicate Bank amounted to Rs. 0.05 Cr with Charge ID 10229637 was registered on 05 Jun 2010. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vikrant Pharmaceuticals Limited?

The CIN of Vikrant Pharmaceuticals Limited is U99999MH1984PLC032190.

Where is Vikrant Pharmaceuticals Limited headquartered?

Vikrant Pharmaceuticals Limited is headquartered at Govind Nivas, 1St Floor,62/64,Dhanji Street, Mumbai, Maharashtra, 400003.

When was Vikrant Pharmaceuticals Limited incorporated?

Vikrant Pharmaceuticals Limited was incorporated on 16 February 1984.

Who are the current directors of Vikrant Pharmaceuticals Limited?

The current directors of Vikrant Pharmaceuticals Limited are

What is the primary industry of Vikrant Pharmaceuticals Limited?

The primary industry of Vikrant Pharmaceuticals Limited is Pharma.

Is Vikrant Pharmaceuticals Limited a listed company?

Vikrant Pharmaceuticals Limited is unlisted.

What is the capital structure of Vikrant Pharmaceuticals Limited?

The authorized capital of Vikrant Pharmaceuticals Limited is ₹6.00 Cr, and the paid-up capital is ₹2.24 Cr.

What is the compliance status of Vikrant Pharmaceuticals Limited?

The compliance status of Vikrant Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available